References
- Aspegren K, Holmberg L, Adami HO. Standardization of the surgical technique in breast-conserving treatment of mammary cancer. Br J Surg 1988; 75: 807–10
- Moher D, Schulz KF, Altman DG. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Lancet 2001; 357: 1191–4
- ICRU: Prescribing and Reporting Photon Beam Therapy. Report # 50. Washington: International Commission on Radiation Units and Measurements; 1993.
- Consensus conference on the classification of ductal carcinoma in situ. Human Pathology 1997;28:1221–5.
- Tavassoli FA, Norris HJ. A comparison of the results of long term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990; 65: 518–29
- Elston CW, Ellis IO. The Breast. Systemic Pathology 13. Churchill Livingstone, Edinburgh 1998
- Machin D, Campbell MJ. Statistical tables for the design of clinical trials2nd ed. Blackwell Science, Oxford 1997
- Kalbfleisch DL, Prentice RL. The statistical analysis of failure time data2nd ed. John Wiley, New York 2002
- Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project Protocol B-17. Cancer 1995; 75: 1310–9
- Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19: 2263–71
- Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328: 1581–6
- Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC RT Group. Lancet 2000; 355: 528–33
- Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 2003; 362: 95–102
- Ringberg A, Moller T. Accrual rate-limiting factors in a Swedish randomised ductal carcinoma in situ (DCIS) trial – a demographic study. Eur J Cancer 2000; 36: 483–8
- Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1990; 26: 671–3
- Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16: 441–52